SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 284.42 millions for the December 2023 quarter as against Rs. 342.18 millions during the year-ago period.The Net Loss for the quarter ended December 2023 is Rs. -29.43 millions as compared to Net Profit of Rs. 29.95 millions of corresponding quarter ended December 2022Operating profit Margin for the quarter ended December 2023 slipped to -10.96% as compared to 49.69% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 284.42 342.18 -16.88 1110.67 731.06 51.93 1153.50 851.40 35.48
Other Income 9.79 19.27 -49.20 30.07 38.70 -22.30 32.73 16.98 92.76
PBIDT -10.96 49.69 -122.06 112.31 111.13 1.06 189.90 136.60 39.02
Interest 5.76 5.76 0.00 16.15 13.39 20.61 20.38 7.94 156.68
PBDT -16.72 43.93 -138.06 96.16 97.74 -1.62 169.52 107.10 58.28
Depreciation 12.71 13.98 -9.08 37.25 38.08 -2.18 53.34 54.93 -2.89
PBT -29.43 29.95 -198.26 58.91 59.66 -1.26 116.18 52.17 122.70
TAX 0.00 0.00 0.00 0.00 0.00 0.00 2.78 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -29.43 29.95 -198.26 58.91 59.66 -1.26 113.40 52.17 117.37
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) -3.85 14.52 -126.54 10.11 15.20 -33.48 16.46 16.04 2.61

Bafna Pharma Share Price

145.00 12.40 (9.35%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×